Ionis Pharmaceuticals, Inc. - IONS

About Gravity Analytica
Recent News
- 11.11.2025 - Webcast from AHA to Discuss Olezarsen CORE and CORE2 Data
- 10.07.2025 - Innovation Day 2025
- 10.07.2025 - Innovation Day 2025
- 09.12.2025 - Ionis expands Surf Away+ event, marking 10 years of creating unique adaptive experiences for people with neurological diseases
- 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
- 09.09.2025 - Ionis receives U.S. FDA Breakthrough Therapy designation for ION582 in Angelman syndrome
- 09.08.2025 - Ionis to host investors and analysts for Innovation Day 2025
- 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
- 09.04.2025 - 2025 Wells Fargo Healthcare Conference
Recent Filings
- 09.11.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.11.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.09.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.09.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.04.2025 - 4 Statement of changes in beneficial ownership of securities